Non-Cell Corynebacterium Parvum Generated by Nanotechnology: A Promising Immunomodulator With Less Side Effects

International Immunopharmacology - Netherlands
doi 10.1016/j.intimp.2007.05.018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Treatment of a Metastasizing Murine Tumour With Corynebacterium Parvum

British Journal of Cancer
Cancer ResearchOncology
1975English

Effects of Corynebacterium Parvum on Escherichia Coli Infection in Mice

Microbiology
Microbiology
1982English

Intrapleural Immunotherapy With Corynebacterium Parvum in Recurrent Malignant Pleural Effusions.

Thorax
PulmonaryRespiratory Medicine
1980English

Intrapleural Corynebacterium Parvum for Malignant Pleural Effusions.

Thorax
PulmonaryRespiratory Medicine
1983English

Factors Affecting Stimulation of Natural Cytotoxicity to a Rat Lymphoma by Corynebacterium Parvum

British Journal of Cancer
Cancer ResearchOncology
1980English

Corynebacterium Parvum. Applications in Experimental and Clinical Oncology

British Journal of Cancer
Cancer ResearchOncology
1976English

Prolonged Fever After Pleural Instillation of Corynebacterium Parvum (Coparvax).

Thorax
PulmonaryRespiratory Medicine
1987English

Coagulation and Fibrinolysis During the Infusion of Corynebacterium Parvum in Man

British Journal of Cancer
Cancer ResearchOncology
1978English

Anti-Tumour Effect in Vitro of Lymphocytes and Macrophages From Mice Treated With Corynebacterium Parvum

British Journal of Cancer
Cancer ResearchOncology
1974English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy